• Skip to primary navigation
  • Skip to main content
  • Skip to footer
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Buscar

Ocultar búsqueda
Shopping Cart
Mostrar búsquedaBuscar
866.626.6847
  • Acerca de
    • Nuestro Trabajo
    • Nuestro Equipo
    • Nuestros Colaboradores
    • Nuestro Impacto
  • Exposiciones
    • Exposiciones Durante el Embarazo y la Lactancia
    • Hojas Informativas
    • Baby Blogs
    • Podcasts
    • Herramienta interactiva
    • Otras Herramientas Educativas
    • App LactRx
  • Estudios
    • Estudios en Curso
    • ¿Qué Está Involucrado?
    • Unirse Ahora
    • Refiere a un Paciente
    • Profesionales de Salud
    • Industria Farmacéutica
    • Publicaciones
  • Profesionales de Salud
    • Educación para Pacientes y Recursos para Proveedores
    • Refiere un Paciente
    • Ordena Materiales
    • Reuniones
  • Medios de Comunicación
    • Solicitudes por los Medios
    • Comunicados de Prensa
    • Inscribirse para Boletín Electrónico
  • En Su Área
  • OTIS
    • Acerca de OTIS
    • Membresía de OTIS
    • Reunión Anual
  • Donar
  • Contactar
  • Mostrar búsquedaBuscar

Cocaine

enero 1, 2025

Selected References:

  • Ackerman JP, et al. 2010. A review of the effects of prenatal cocaine exposure among school-aged children. Pediatrics 125(3):554-565.  
  • Akyuz N, et al. 2014. Structural brain imaging in children and adolescents following prenatal cocaine exposure: preliminary longitudinal findings. Dev Neurosci. 316-28. 
  • Behnke M, et al. 2001. The search for congenital malformations in newborns with fetal cocaine exposure. Pediatrics 107(5):E74.  
  • Bracken MB, et al. 1990. Association of cocaine use with sperm concentration, motility, and morphology. Fertil Steril 53:315-322  
  • British Columbia Reproductive Care Program. 1999. Substance Use Guideline 5B: Prenatal Cocaine Exposure, Care of the Newborn. Retrieved from: www.perinatalservicesbc.ca/Documents/Guidelines-Standards/Newborn/CocaineExposureNewbornCareGuideline.pdf.  
  • Cestonari, C, et al. 2022. Infants of mothers with cocaine use: Review of clinical and medico-legal aspects. Children 9(1):67-84. 
  • Chiriboga C, et al. 2007. Prenatal cocaine exposures and dose-related cocaine effects on infant tone and behavior. Neurotoxicol Teratol29: 323-330.  
  • Chiriboga CA, et al. 2009. Prenatal cocaine exposure and prolonged focus attention. Poor infant information processing ability or precocious maturation of attentional systems? Dev Neurosci 31(1-2):149-158.  
  • Cone EJ, et al. 1996. Cocaine excretion in the semen of drug users. J Anal Toxicol 20:139-140.  
  • De Genna, N. M., Goldschmidt, L., & Richardson, G. A. (2022). Prenatal cocaine exposure, early cannabis use, and risky sexual behavior at age 25. Neurotoxicology and teratology, 89, 107060. https://doi.org/10.1016/j.ntt.2021.107060 
  • Dos Santos JF, et al. 2018. Maternal, fetal and neonatal consequences associated with the use of crack cocaine during the gestational period: a systematic review and meta-analysis. Arch Gynecol Obstet. 298(3):487-503. 
  • Hoyme HE, et al. 1990. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 85:743-747.  
  • Jufer RA, et al. 2000. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. Journal of analytical toxicology; 24(7), 467–477. 
  • Karpova N, 2021. Prenatal drug exposure and executive function in early adolescence. Neurotoxicology and teratology; 88, 107036.  
  • Landi N, et al. 2017. Prenatal Cocaine Exposure Impacts Language and Reading Into Late Adolescence: Behavioral and ERP Evidence. Dev Neuropsychol. 42(6):369-386.  
  • Levine TP, et al. 2008. Effects of prenatal cocaine exposure on special education in school-aged children. Pediatrics 122 (1): e83-91.  
  • Lewis BA, et al. 2007. Prenatal cocaine and tobacco effects on children’s language trajectories. Pediatrics 120(1):e78-85.  
  • Mayer LC, Nicholls S. 2007. Neurocognitive development in middle-school age and adolescent prenatally cocaine-exposed children. Birth Def Res (Part A) 79:381-394.  
  • Modernel XD, et al. 2017. Use of crack in pregnancy: repercussions for the newborn.Invest Educ Enferm. 35(3). 
  • Montgomery DP, et al. 2008. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey. J Perinatol 28(11):750-753.  
  • Morie KP, et al. 2020. Alexithymia, Emotion-Regulation Strategies, and Traumatic Experiences in Prenatally Cocaine-Exposed Young Adults. The American journal on addictions; 29(6), 492–499.  
  • National Institute on Drug Abuse. “Substance Use While Pregnant and Breastfeeding.” National Institute on Drug Abuse, 2020, 
  • National Library of Medicine (US), 2006. “Cocaine” 
  • Ness RB, et al. 1999. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl Med 340(5):333-339.s 
  • Oliveira TA, et al. 2016. Perinatal outcomes in pregnant women users of illegal drugs. Rev Bras Ginecol Obstet. 38(4):183-188. 
  • Pires A, et al 2012. Repeated inhalation of crack-cocaine affects spermatogenesis in young and adult mice. Inhal Toxicol. 24(7):439-446.  
  • Reece-Stremtan S, Marinelli KA. 2015. ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015. Breastfeed Med. 10(3):135-41. 
  • Richardson GA, et al. 2007.Effects of prenatal cocaine exposure on growth: a longitudinal analysis. Pediatrics. 120(4): e1017-1027.  
  • Richardson GA, et al. 2010. Prenatal cocaine exposure: Effects on mother- and teacher-rated behavior problems and growth in school-age children. Neurotoxicol Teratol.  
  • Richardson GA, et al. 2015. Effects of prenatal cocaine exposure on adolescent development. Neurotoxicol Teratol. 49:41-8. 
  • Roussotte F, et al. 2010. Structural, metabolic, and functional brain abnormalities as a result of prenatal exposure to drugs of abuse: evidence from neuroimaging. Neuropsychol Rev.  
  • Salzwedel A, et al. 2020. Functional dissection of prenatal drug effects on baby brain and behavioral development. Human brain mapping; 41(17), 4789–4803. 
  • Semet M, et al. 2017. The impact of drugs on male fertility: a review. Andrology 5:640-63.  
  • Serino D, et al. 2018. Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood. J Dual Diagn. 25:1-13. 
  • Singer LT, et al. 2000. Neurobehavioral outcomes of cocaine-exposed infant. Neurotoxical Teratol 22(5):653-666.  
  • Singer LM, et al. 2008. Prenatal cocaine exposure: drug and environmental effects at 9 years. J Pediatr 153(1): 105-111.  
  • Van Gelder MMHJ, et al. 2009. Maternal periconceptional illicit drug use and the risk of congenital malformations. Epidemiology 20(1):60-66.  
  • Weathers WT, et al. 1993. Cocaine use in women from a defined population: prevalence at delivery and effects of growth in infants. Pediatrics 91(2):326-239.  
  • Yazigi RA, et al. 1991. Demonstration of specific binding of cocaine to human spermatozoa. JAMA 266:1956-1959. 

Footer

               

Enlaces Candentes

  • Página Principal
  • Exposiciones
  • Hojas Informativas
  • Baby Blogs
  • Podcasts
  • Estudios de Embarazo
  • Unirse a un Estudio Ahora
  • Profesionales de Salud
  • Refiere un Paciente
  • Ordena Materiales
  • Comunicados de Prensa
  • Donar
  • Pregúntele a un Experto

Estudios en Curso

  • Espondilitis Anquilosante
  • Estreñimiento
  • Coronavirus (COVID-19)
  • Eccema (Moderado-a-Severo)/Dermatitis Atópica
  • Hidradenitis Supurative
  • Lupus
  • Esclerosis Múltiple
  • Psoriasis
  • Artritis Psoriásica

Contactar

Servicio de Información de Exposición
866.626.6847

Estudios de Embarazo
877.311.8972

Consultas de los Medios
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, un servicio de la Organización de Especialistas en Información de Teratología

Derechos de autor © 2025 la Organización de Especialistas en Información de Teratología

  • Accesibilidad
  • Términos
  • Confidencialidad
  • Mapa del Sitio
^

MotherToBaby cuenta con el apoyo de la Administración de Recursos y Servicios de Salud (HRSA) del Departamento de Salud y Servicios Humanos de los Estados Unidos (HHS) como parte de una adjudicación por un total de $6,000,000 con cero porcentaje financiado con fuentes no gubernamentales. Los contenidos son los del autor/es y no representan necesariamente los puntos de vista oficiales de, ni un respaldo, por HRSA, HHS o el Gobierno de los Estados Unidos.